Correction: MPT0B169, a New Antitubulin Agent, Inhibits Bcr-Abl Expression and Induces Mitochondrion-Mediated Apoptosis in Nonresistant and Imatinib-Resistant Chronic Myeloid Leukemia Cells.

PLoS One

Published: October 2017

[This corrects the article DOI: 10.1371/journal.pone.0148093.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636148	PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186531	PLOS

Publication Analysis

correction mpt0b169

mpt0b169 antitubulin

antitubulin agent

agent inhibits

inhibits bcr-abl

bcr-abl expression

expression induces

induces mitochondrion-mediated

mitochondrion-mediated apoptosis

apoptosis nonresistant

PLoS One

October 2017

[This corrects the article DOI: 10.1371/journal.pone.

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!